Professor, Internal Medicine, Mayo Medical School. Director William J. von Liebig Center for Tranplantation and Clinical Regeneration
Cardiology
Dr. Brooks S. Edwards, MD
|
|
Give Review
Brooks Edwards practices Cardiology. He went to Mayo Medical School. Mayo Medical School has a rank of 27 in research and a 42 in primary care He has 1 awards "Fellow (FACC)". Brooks Edwards is also a published doctor. He has 91 paper published. The most recent paper is: Disseminated Kaposi's sarcoma after heart transplantation: association with Kaposi's sarcoma-associated herpesvirus. Brooks Edwards is registered with Medicare.
Publications
- Cardiac transplantation for radiation-induced Cardiomyopathy: the mayo clinic experience.
- Early Trends in N-Terminal Pro-Brain Natriuretic Peptide Values After Left Ventricular Assist Device Implantation for Chronic Heart Failure.
- TPMT genetic variants are associated with increased rejection with azathioprine use in Heart transplantation.
- Role of Echocardiography in Patients With Intravascular Hemolysis Due to Suspected Continuous-Flow LVAD Thrombosis.
- Left ventricular device implantation for advanced cardiac amyloidosis.
- Decreased Postoperative Atrial Fibrillation Following Cardiac Transplantation: The Significance of Autonomic Denervation.
- Donor-Specific Antibodies to Class II Antigens Are Associated With Accelerated Cardiac Allograft Vasculopathy: A Three-Dimensional Volumetric Intravascular Ultrasound ...
- Combined Heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation.
- Readmissions after implantation of axial flow left ventricular assist device.
- Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival.
- Seligman's theory of attributional style: optimism, pessimism, and quality of life after Heart transplant.
- Changes in renal function after implantation of continuous-flow left ventricular assist devices.
- Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy with Improved Late Survival and Decreased Cardiac Events Following Cardiac Transplantation.
- Cardiac allograft hypertrophy is associated with impaired exercise tolerance after Heart transplantation.
- Regenerative medicine: a reality of stem cell technology.
- Hand transplantation.
- B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
- Combined Heart and liver transplantation: a single-center experience.
- Features of cardiac allograft Coronary endothelial dysfunction.
- Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
- Neuromuscular Diseases after cardiac transplantation.
- Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft.
- Autologous stem cell transplant after heart transplant for light chain (Al) amyloid Cardiomyopathy.
- Effect of infectious Diseases on outcome after heart transplant.
- Effect of neurologic complications on outcome after Heart transplant.
- Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
- Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
- Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
- Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy.
- Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
- Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy.
- Heart and liver Disease in 32 patients undergoing biopsy of both organs, with implications for heart or liver transplantation.
- OKT3 neurotoxicity presenting as akinetic mutism.
- Clinical predictors of exercise capacity 1 year after cardiac transplantation.
- Partial normalization of the Heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity.
- The Role of Medical Management for Acute Intravascular Hemolysis in Patients Supported on Axial Flow LVAD.
- Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced Heart failure patients.
- Sirolimus as primary immunosuppression is associated with improved Coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipi...
- Prevalence, pathophysiology, and clinical significance of post-heart transplant Atrial fibrillation and Atrial flutter.
- Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial.
- Prognostic features in patients with congestive Heart failure and selection criteria for cardiac transplantation.
- Total lymphoid irradiation: a novel and successful therapy for resistant cardiac allograft rejection.
- Methylergonovine-induced diffuse coronary spasm in a patient with exercise-induced coronary spasm after Heart transplantation.
- Disseminated Kaposi's sarcoma after Heart transplantation: association with Kaposi's sarcoma-associated herpesvirus.
- Predictors of reversibility of Pulmonary hypertension in cardiac transplant recipients in the first postoperative year.
- Increased incidence of chronotropic incompetence in older donor Hearts.
- Increase in total plasma homocysteine concentration after cardiac transplantation.
- Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation.
- Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
- Fatal disseminated aspergillosis following sequential Heart and stem cell transplantation for systemic amyloidosis.
- Cardiac allograft remodeling after Heart transplantation is associated with increased graft vasculopathy and mortality.
- Presence of Atrial natriuretic factor in ventricular tissue in tachycardia-induced cardiomyopathy.
- Expression of Atrial natriuretic factor in the human ventricle is independent of chamber dilation.
- Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
- Diagnosis of coronary artery atheroEmbolism by right ventricular endomyocardial biopsy.
- Extended donor use for Heart transplantation.
- Combined Heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy.
- Failure of atrial natriuretic factor to increase with volume expansion in Acute and chronic congestive heart failure in the dog.
- Role of renal Na+,K(+)-ATPase in the regulation of sodium excretion under normal conditions and in Acute congestive heart failure.
- Intracardiac ectopic thyroid.
- Heart transplantation for radiation-associated end-stage Heart failure.
- Restoration of renal response to Atrial natriuretic factor in experimental low-output heart failure.
- Identification of Atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure.
- Cardiac Atrial natriuretic factor during evolution of congestive heart failure.
- Role of endogenous atrial natriuretic factor in Acute congestive heart failure.
- Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal Hypertension.
- Cardiac transplantation in patients with preexisting neoplastic Diseases.
- Renal-endocrine adaptations to endogenous Atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure.
- The synergistic effects of cyclosporine and endothelin--demonstration of an important cardiodepressor action.
- Coexistent Pulmonary and portal hypertension: morphologic and clinical features.
- Renal response to Atrial natriuretic factor is modulated by intrarenal angiotensin II.
- Arrhythmogenic right ventricular dysplasia masquerading as dilated Cardiomyopathy.
- Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of Atrial natriuretic factor in the dog.
- Recent advances in cardiac transplantation.
- Atrial natriuretic peptide decreases cardiac output independent of coronary vasoconstriction.
- Role of Atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhage.
- Atrial stretch, not pressure, is the principal determinant controlling the Acute release of atrial natriuretic factor.
- Counseling: implementing our knowledge in a hurried and complex world.
- The relationship between Atrial granularity and circulating Atrial natriuretic peptide in hamsters with congestive heart failure.
- Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs.
- The sodium retaining effects of cyclosporine.
- Atrial natriuretic factor: physiologic actions and implications in congestive heart failure.
- Congestive Heart failure in rheumatic carditis: valvular or myocardial origin?
- A stop at the Oasis. Lessons from the Mayo Clinic's popular Web site.
- Isolated renal Artery dissection, presentation, evaluation, management, and pathology.
- Aneurysms of aberrant right subclavian arteries.
- Hypertension and Heart failure: the link continues.
- Ventricular septal rupture complicating Acute myocardial infarction: identification of simple and complex types in 53 autopsied hearts.
- Morphologic changes in the Pulmonary arteries after percutaneous balloon angioplasty for Pulmonary arterial stenosis.
- Aortic origin of conus coronary artery. Evidence of postnatal coronary development.
Schools
Mayo Medical School
Mayo Foundation For Med Education and Research
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioversion, Elective
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Autonomic Disorders
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- Medica
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (FACC)
Education
-
Stanford University -
Mayo School of Graduate Medical Education -
Mayo Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1386614543 | |
| NPPES Provider LastName | EDWARDS | |
| NPPES Provider FirstName | BROOKS | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 567.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386614543 |
| Last Name Of The Provider | EDWARDS |
| First Name Of The Provider | BROOKS |
| View All |
Similar Doctors
|
|
Dr. Alan K. Duncan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. McBane, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Fletcher A. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel J. Asirvatham, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Taylor F. Dowsley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond J. Gibbons, MD |
|
|
Dr. David L. Hayes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sridevi R. Pitta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charanjit S. Rihal, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gregory W. Barsness, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mandeep Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sithu Win, MD |
|
|
Dr. Imran S. Syed, MD |